查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1782642

全球伴侣动物药物市场研究报告 - 产业分析、规模、份额、成长、趋势及 2025 年至 2033 年预测

Global Companion Animal Medicine Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 161 Pages | 商品交期: 最快1-2个工作天内

价格

全球伴侣动物药物市场规模预计将从 2024 年的 191.2 亿美元成长到 2033 年的 338.4 亿美元，在 2026 年至 2033 年的预测期内，年复合成长率(CAGR) 将达到 6.55%。

伴侣动物药品市场正经历显着成长，这得益于宠物拥有量的不断增长以及人们对动物健康和保健意识的不断提升。随着越来越多的家庭开始接纳宠物，对兽医服务和产品的需求也随之激增。宠物主人在寻求预防性护理方面也变得更加积极主动，这推动了疫苗、诊断和治疗药物市场的成长。这一趋势在宠物拥有率较高的地区尤其明显，因为这些地区的消费者愿意为宠物的健康和福祉投资。随着市场的不断发展，兽医技术和技术的创新有望提升伴侣动物的照护品质。

此外，宠物人性化趋势日益增长，也显着影响伴侣动物医疗市场。随着宠物日益被视为家庭成员，主人也开始寻求与人类医疗保健标准相符的高品质医疗服务。这种转变推动了对先进治疗的需求，包括针对伴侣动物独特需求的专科手术、牙科护理和营养补充剂。此外，远距医疗在兽医护理领域的兴起，使宠物主人更容易获得专业的建议和服务，从而进一步扩大了市场。随着人们对宠物健康和保健的关注度不断提高，伴侣动物医疗市场预计将蓬勃发展，以满足宠物主人不断变化的需求。

此外，研发领域的进步也促进了伴侣动物药品市场的发展。新型药物、生物製剂和诊断工具的出现，提高了诊断和治疗宠物各种疾病的能力。随着兽医专业人员获得更有效的治疗方案，伴侣动物的整体护理品质有望得到提升。此外，兽医专业人员与宠物产品製造商之间日益增多的合作，也促进了市场创新，从而催生出新的有效解决方案。随着伴侣动物药品市场的不断发展，在对高品质兽医护理日益增长的需求的推动下，该市场有望持续增长。

我们的报告经过精心设计，旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分，以确保客户全面了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准，将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了竞争态势以及领先公司采用的关键策略。

市场预测：根据历史资料和当前市场状况，对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示，以说明未来的市场发展轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前及新兴市场趋势、技术创新以及潜在投资领域。本部分将深入探讨未来市场发展与成长前景。

目录

第一章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第三章：伴侣动物医药产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按适应症分析市场吸引力
    • 按给药途径进行的市场吸引力分析
    • 依动物类型分析市场吸引力
    • 按配销通路分析市场吸引力
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第五章：全球伴侣动物药物市场分析：按适应症

  • 按适应症概述
  • 依适应症分析历史和预测数据
  • 传染病
  • 皮肤病（皮肤病）
  • 疼痛
  • 骨科疾病
  • 行为障碍
  • 其他（牙科、心臟、怀孕、癌症）

第六章：全球伴侣动物药物市场分析：依给药途径

  • 依给药途径概述
  • 按给药途径进行的历史和预测数据分析
  • 口服
  • 注射剂
  • 外用

第七章：全球伴侣动物药物市场分析：依动物类型

  • 依动物类型概述
  • 按动物类型进行的历史和预测数据分析
  • 狗
  • 猫
  • 马匹
  • 其他伴侣动物

第 8 章：全球伴侣动物药物市场分析：按分销管道

  • 按配销通路概览
  • 按配销通路进行的历史和预测资料分析
  • 兽医院
  • 兽医诊所
  • 零售药局

第九章：全球伴侣动物药物市场分析：按地区

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第十章：伴侣动物药品公司的竞争格局

  • 伴侣动物药物市场竞争
  • 伙伴关係/合作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Zoetis
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck Animal Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Boehringer Ingelheim Animal Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Elanco Animal Health
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Ceva SantA(C) Animale
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Virbac
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Dechra Pharmaceuticals
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Vetoquinol
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Neogen Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Orion Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Norbrook Holdings
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Chanelle Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • HIPRA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Kyoritsu Seiyaku
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BiogA(C)NA(C)Sis BagA3
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR112110630

Global Companion Animal Medicine Market size is anticipated to grow from USD 19.12 Billion in 2024 to USD 33.84 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.55% during the forecast period of 2026 to 2033.

The companion animal medicine market is experiencing significant growth, driven by the increasing pet ownership and the rising awareness of animal health and wellness. As more households welcome pets into their lives, the demand for veterinary services and products is surging. Pet owners are becoming more proactive in seeking preventive care, leading to a growing market for vaccines, diagnostics, and therapeutic treatments. This trend is particularly pronounced in regions with high pet ownership rates, where consumers are willing to invest in the health and well-being of their animals. As the market continues to evolve, innovations in veterinary medicine and technology are expected to enhance the quality of care available for companion animals.

Moreover, the growing trend of pet humanization is significantly influencing the companion animal medicine market. As pets are increasingly viewed as family members, owners are seeking high-quality medical care that mirrors human healthcare standards. This shift is driving demand for advanced treatments, including specialized surgeries, dental care, and nutritional supplements tailored to the unique needs of companion animals. Additionally, the rise of telemedicine in veterinary care is making it easier for pet owners to access professional advice and services, further expanding the market. As the focus on pet health and wellness continues to grow, the companion animal medicine market is expected to thrive, catering to the evolving needs of pet owners.

Furthermore, advancements in research and development are enhancing the companion animal medicine market. The emergence of new pharmaceuticals, biologics, and diagnostic tools is improving the ability to diagnose and treat various conditions in pets. As veterinary professionals gain access to more effective treatment options, the overall quality of care for companion animals is expected to improve. Additionally, the increasing collaboration between veterinary professionals and pet product manufacturers is fostering innovation in the market, leading to the development of new and effective solutions. As the companion animal medicine market continues to evolve, it is likely to witness sustained growth, driven by the increasing demand for high-quality veterinary care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Indication

  • Infectious Diseases
  • Dermatologic Diseases (Skin Diseases)
  • Pain
  • Orthopedic Diseases
  • Behavioral Disorders
  • Others (Dental, Cardio, Pregnancy, Cancer)

By Route of Administration

  • Oral
  • Injectable
  • Topical

By Animal Type

  • Dogs
  • Cats
  • Horses
  • Other Companion Animals

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • COMPANIES PROFILED
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Ceva Sante Animale
  • Virbac
  • Dechra Pharmaceuticals
  • Vetoquinol
  • Neogen Corporation
  • Orion Group
  • Norbrook Holdings
  • Chanelle Pharma
  • HIPRA
  • Kyoritsu Seiyaku
  • Biogenesis Bago.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. COMPANION ANIMAL MEDICINE INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Indication
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Animal Type
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY INDICATION

  • 5.1. Overview By Indication
  • 5.2. Historical and Forecast Data Analysis By Indication
  • 5.3. Infectious Diseases Historic and Forecast Sales By Regions
  • 5.4. Dermatologic Diseases (Skin Diseases) Historic and Forecast Sales By Regions
  • 5.5. Pain Historic and Forecast Sales By Regions
  • 5.6. Orthopedic Diseases Historic and Forecast Sales By Regions
  • 5.7. Behavioral Disorders Historic and Forecast Sales By Regions
  • 5.8. Others (Dental, Cardio, Pregnancy, Cancer) Historic and Forecast Sales By Regions

6. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data Analysis By Route of Administration
  • 6.3. Oral Historic and Forecast Sales By Regions
  • 6.4. Injectable Historic and Forecast Sales By Regions
  • 6.5. Topical Historic and Forecast Sales By Regions

7. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY ANIMAL TYPE

  • 7.1. Overview By Animal Type
  • 7.2. Historical and Forecast Data Analysis By Animal Type
  • 7.3. Dogs Historic and Forecast Sales By Regions
  • 7.4. Cats Historic and Forecast Sales By Regions
  • 7.5. Horses Historic and Forecast Sales By Regions
  • 7.6. Other Companion Animals Historic and Forecast Sales By Regions

8. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Veterinary Hospitals Historic and Forecast Sales By Regions
  • 8.4. Veterinary Clinics Historic and Forecast Sales By Regions
  • 8.5. Retail Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL MEDICINE COMPANIES

  • 10.1. Companion Animal Medicine Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF COMPANION ANIMAL MEDICINE INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Zoetis
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Merck Animal Health
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Boehringer Ingelheim Animal Health
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Elanco Animal Health
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Ceva SantA(C) Animale
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Virbac
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Dechra Pharmaceuticals
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Vetoquinol
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Neogen Corporation
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Orion Group
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Norbrook Holdings
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Chanelle Pharma
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. HIPRA
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Kyoritsu Seiyaku
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. BiogA(C)NA(C)Sis BagA3
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Indication (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Dermatologic Diseases (Skin Diseases) Market Sales By Geography (USD MN)
  • Pain Market Sales By Geography (USD MN)
  • Orthopedic Diseases Market Sales By Geography (USD MN)
  • Behavioral Disorders Market Sales By Geography (USD MN)
  • Others (Dental, Cardio, Pregnancy, Cancer) Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Analysis By Animal Type (USD MN)
  • Dogs Market Sales By Geography (USD MN)
  • Cats Market Sales By Geography (USD MN)
  • Horses Market Sales By Geography (USD MN)
  • Other Companion Animals Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Veterinary Hospitals Market Sales By Geography (USD MN)
  • Veterinary Clinics Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Companion Animal Medicine Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Companion Animal Medicine Report
  • Market Research Process
  • Market Research Methodology
  • Global Companion Animal Medicine Market Size, By Regions (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Animal Type
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Regions
  • Value Chain Analysis
  • Global Market Analysis By Indication (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Dermatologic Diseases (Skin Diseases) Market Sales By Geography (USD MN)
  • Pain Market Sales By Geography (USD MN)
  • Orthopedic Diseases Market Sales By Geography (USD MN)
  • Behavioral Disorders Market Sales By Geography (USD MN)
  • Others (Dental, Cardio, Pregnancy, Cancer) Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectable Market Sales By Geography (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Global Market Analysis By Animal Type (USD MN)
  • Dogs Market Sales By Geography (USD MN)
  • Cats Market Sales By Geography (USD MN)
  • Horses Market Sales By Geography (USD MN)
  • Other Companion Animals Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Veterinary Hospitals Market Sales By Geography (USD MN)
  • Veterinary Clinics Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.